BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30867344)

  • 1. Effects of Tetrahydrobiopterin Combined with Nebivolol on Cardiac Diastolic Function in SHRs.
    Zhang Z; Lu C; Meng Y; Wang Q; Guan X; Yu J
    Biol Pharm Bull; 2019 Jul; 42(7):1102-1111. PubMed ID: 30867344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebivolol combined with tetrahydrobiopterin affects diastolic function in spontaneously hypertensive rats via the nitric oxide/cyclic guanosine monophosphate signalling pathway.
    Guan X; Guan X; Lu C; Shang B; Zhao Y; Meng Y; Zhang Z
    BMC Pharmacol Toxicol; 2020 Dec; 21(1):84. PubMed ID: 33267901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
    Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
    Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tetrahydrobiopterin improves left ventricular diastolic function possibly through upregulating phosphorylated protein kinase B expression in hypertensive mice induced by deoxycorticosterone acetate].
    Wang QY; Yang MN; Xu H; Zhao Y; Lin X; Zhang XW; Zhao F; Zhao X; Kou XQ; Bai F; Yu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):759-765. PubMed ID: 27667273
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetrahydrobiopterin reverse left ventricular hypertrophy and diastolic dysfunction through the PI3K/p-Akt pathway in spontaneously hypertensive rats.
    Chang P; Wang Q; Xu H; Yang M; Lin X; Li X; Zhang Z; Zhang X; Zhao F; Zhao X; Bai F; Yu J
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1012-20. PubMed ID: 26093301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydrobiopterin (BH
    Francis BN; Salameh M; Khamisy-Farah R; Farah R
    Cardiovasc Ther; 2018 Feb; 36(1):. PubMed ID: 29151278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats.
    Wang Y; Zhang F; Liu Y; Yin S; Pang X; Li Z; Wei Z
    Clin Exp Hypertens; 2017; 39(7):628-639. PubMed ID: 28640644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of nitric oxide/cGMP/PKG signaling cascade mediates antihypertensive effects of Muntingia calabura in anesthetized spontaneously hypertensive rats.
    Shih CD
    Am J Chin Med; 2009; 37(6):1045-58. PubMed ID: 19938215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
    Itoh T; Haruna M; Abe K
    Exp Physiol; 2007 Jan; 92(1):147-59. PubMed ID: 17030559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
    Wang Y; Zhang M; Liu Y; Liu Y; Chen M
    Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy.
    Ognibene DT; Moss MB; Matsuura C; Brunini TM; de Moura RS; Mendes-Ribeiro AC; Resende AC
    Hypertens Res; 2010 Sep; 33(9):899-904. PubMed ID: 20555333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KMUP-1 inhibits hypertension-induced left ventricular hypertrophy through regulation of nitric oxide synthases, ERK1/2, and calcineurin.
    Yeh JL; Liu CP; Hsu JH; Tseng CJ; Wu PJ; Wang YY; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2012 Nov; 28(11):567-76. PubMed ID: 23140764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo gum arabic-coated tetrahydrobiopterin protects against myocardial ischemia reperfusion injury by preserving eNOS coupling.
    Xie L; Hu D; Qin H; Zhang W; Zhang S; Feng Y; Yao H; Xiao Y; Yao K; Huang X
    Life Sci; 2019 Feb; 219():294-302. PubMed ID: 30668954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sesamin enhances nitric oxide bioactivity in aortas of spontaneously hypertensive rats.
    Kong X; Li W; Guo LQ; Zhang JX; Chen XP; Liu WY; Yang JR
    Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):314-24. PubMed ID: 26037786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced activation of NAD(P)H: quinone oxidoreductase 1 attenuates spontaneous hypertension by improvement of endothelial nitric oxide synthase coupling via tumor suppressor kinase liver kinase B1/adenosine 5'-monophosphate-activated protein kinase-mediated guanosine 5'-triphosphate cyclohydrolase 1 preservation.
    Kim YH; Hwang JH; Kim KS; Noh JR; Gang GT; Oh WK; Jeong KH; Kwak TH; Choi HS; Lee IK; Lee CH
    J Hypertens; 2014 Feb; 32(2):306-17. PubMed ID: 24241058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endothelial nitric oxide synthase cofactor tetrahydrobiopterin shields the remote myocardium from apoptosis after experimental myocardial infarction in vivo.
    Heidrich FM; Jercke MC; Ritzkat A; Ebner A; Poitz DM; Pfluecke C; Quick S; Speiser U; Simonis G; Wäßnig NK; Strasser RH; Wiedemann S
    Kardiol Pol; 2017; 75(12):1339-1350. PubMed ID: 28832096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
    Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
    J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure.
    Westermann D; Riad A; Richter U; Jäger S; Savvatis K; Schuchardt M; Bergmann N; Tölle M; Nagorsen D; Gotthardt M; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2009 Sep; 104(5):499-509. PubMed ID: 19255799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Involvement of ET-1/eNOS in the ameliorating effect of electroacupuncture on cardiac dysfunction in rats with spontaneously hypertensive].
    Xin JJ; Gao JH; Liu Q; Zhao YX; Zhou C; Yu XC
    Zhongguo Zhen Jiu; 2022 Jun; 42(6):647-53. PubMed ID: 35712949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BH4 Increases nNOS Activity and Preserves Left Ventricular Function in Diabetes.
    Carnicer R; Duglan D; Ziberna K; Recalde A; Reilly S; Simon JN; Mafrici S; Arya R; Roselló-Lletí E; Chuaiphichai S; Tyler D; Lygate CA; Channon KM; Casadei B
    Circ Res; 2021 Mar; 128(5):585-601. PubMed ID: 33494625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.